Oxford Pharmascience - Successful completion of PoC for OXPzero Ibuprofen

CEO Marcelo Braco speaks about the body of data collected across the two studies that demonstrate that OXPzero Ibuprofen is a differentiated, superior form of ibuprofen delivering a range of benefits over the standard drug across multiple parameters.

Marcelo Bravo
Chief Executive Officer

Company Events - OXFORD PHARMASCIENCE GROUP